GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹13,322 Cr | ₹11,813 Cr | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹13,322 Cr |
| Mar2025 | ₹11,813 Cr |
| Mar2024 | ₹11,583 Cr |
| Mar2023 | ₹12,305 Cr |
| Mar2022 | ₹10,944 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,322 Cr | 12.77 | |
| Mar2025 | ₹11,813 Cr | 1.98 | |
| Mar2024 | ₹11,583 Cr | -5.86 | |
| Mar2023 | ₹12,305 Cr | 12.44 | |
| Mar2022 | ₹10,944 Cr | - | |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹68,207.7 Cr | -0.4% | 6.4% | 18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.4% |
6.4% |
18.8% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses